Repligen RGEN
NASDAQ RGEN
$164.68 -0.37 (-0.22%)
As of: Sep 10, 2026 · 3:59 PM EDT

Repligen (RGEN) FCF Margin (QoQ) (2010 - 2026)

Analysis

Repligen (RGEN) FCF Margin (QoQ) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 223.99 Bn 219.93 Bn 8.34 Bn
2 Danaher 141.56 Bn 137.22 Bn 3.61 Bn
3 Agilent Technologies 40.36 Bn 38.60 Bn 1.04 Bn
4 Illumina 30.41 Bn 29.24 Bn 770.00 Mn
5 Revvity 13.50 Bn 12.48 Bn 416.87 Mn
6 Bio-Techne 11.25 Bn 10.98 Bn 211.39 Mn
7 Bio-Rad Laboratories 9.88 Bn 8.26 Bn 345.80 Mn
8 Repligen 9.29 Bn 8.28 Bn 110.04 Mn
9 10x Genomics 8.62 Bn 8.06 Bn 112.50 Mn
10 Bruker 8.16 Bn 7.94 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 130.00
Mar 31, 2026 327.00
Dec 31, 2025 -1,412.00
Sep 30, 2025 1,119.00
Jun 30, 2025 503.00
Mar 31, 2025 -1,331.00
Dec 31, 2024 -726.00
Sep 30, 2024 380.00
Jun 30, 2024 -20.00
Mar 31, 2024 1,295.00
Dec 31, 2023 -1,106.00
Sep 30, 2023 537.00
Jun 30, 2023 1,488.00
Mar 31, 2023 -2,059.00
Dec 31, 2022 747.00
Sep 30, 2022 492.00
Jun 30, 2022 1,178.00
Mar 31, 2022 -1,136.00
Dec 31, 2021 288.00
Sep 30, 2021 -648.00